Oxidized Low-Density Lipoprotein Induces Long-Term Proinflammatory Cytokine Production and Foam Cell Formation via Epigenetic Reprogramming of Monocytes

被引:514
作者
Bekkering, Siroon [1 ]
Quintin, Jessica [1 ]
Joosten, Leo A. B. [1 ]
van der Meer, Jos W. M. [1 ]
Netea, Mihai G. [1 ]
Riksen, Niels P. [2 ,3 ]
机构
[1] Radboud Univ Nijmegen Med Ctr, Dept Internal Med, Div Expt Med, NL-6500 HB Nijmegen, Netherlands
[2] Radboud Univ Nijmegen Med Ctr, Div Vasc Med, NL-6500 HB Nijmegen, Netherlands
[3] Radboud Univ Nijmegen Med Ctr, Dept Pharmacol Toxicol, NL-6500 HB Nijmegen, Netherlands
关键词
atherosclerosis; epigenomics; inflammation; monocytes; oxidized low-density lipoprotein; MEDIATED HISTONE MODIFICATIONS; RECEPTOR-DEFICIENT MICE; HUMAN ENDOTHELIAL-CELLS; MYOCARDIAL-INFARCTION; STERILE INFLAMMATION; TRAINED IMMUNITY; GENE-EXPRESSION; ATHEROSCLEROSIS; MACROPHAGES; ACTIVATION;
D O I
10.1161/ATVBAHA.114.303887
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective-Although the role of monocytes in the pathogenesis of atherosclerosis is well established, the persistent vascular inflammation remains largely unexplained. Recently, our group reported that stimulation of monocytes with various microbial products can induce a long-lasting proinflammatory phenotype via epigenetic reprogramming, a process termed trained immunity. We now hypothesize that oxidized low-density lipoprotein (oxLDL) also induces a long-lasting proinflammatory phenotype in monocytes, which accelerates atherosclerosis by proinflammatory cytokine production and foam cell formation. Approach and Results-Isolated human monocytes were exposed for 24 hours to medium or oxLDL. After washing and resting for 6 days, the cells were exposed to toll-like receptor 2 and 4 agonists. Pre-exposure to oxLDL increased mRNA expression and protein formation on toll-like receptor 2 and 4 stimulation of several proatherogenic proteins, including interleukin-6, interleukin-18, interleukin-8, tumor necrosis factor-alpha, monocyte chemoattractant protein 1, and matrix metalloproteinase 2 and 9. In addition, foam cell formation was enhanced after oxLDL exposure, which was associated with an upregulation of scavenger receptors CD36 and scavenger receptor-A and downregulation of ATP-binding cassette transporters, ABCA1 and ABCG1. Chromatin immunoprecipitation performed 6 days after oxLDL stimulation demonstrated increased trimethylation of lysine 4 at histone 3 in promoter regions of tnf alpha, il-6, il-18, mcp-1, mmp2, mmp9, cd36, and sr-a. Finally, pretreatment of the monocytes with the histone methyltransferase inhibitor methylthioadenosine completely prevented the oxLDL-induced long-lasting proinflammatory phenotype. Conclusions-Brief exposure of monocytes to a low concentration of oxLDL induces a long-lasting proatherogenic macrophage phenotype via epigenetic histone modifications, characterized by increased proinflammatory cytokine production and foam cell formation.
引用
收藏
页码:1731 / +
页数:19
相关论文
共 33 条
[1]   TNF/iNOS-producing dendritic cells are the necessary evil of lethal influenza virus infection [J].
Aldridge, Jerry R., Jr. ;
Moseley, Carson E. ;
Boltz, David A. ;
Negovetich, Nicholas J. ;
Reynolds, Cory ;
Franks, John ;
Brown, Scott A. ;
Doherty, Peter C. ;
Webster, Robert G. ;
Thomas, Paul G. .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2009, 106 (13) :5306-5311
[2]   Trained innate immunity and atherosclerosis [J].
Bekkering, Siroon ;
Joosten, Leo A. B. ;
van der Meer, Jos W. M. ;
Netea, Mihai G. ;
Riksen, Niels P. .
CURRENT OPINION IN LIPIDOLOGY, 2013, 24 (06) :487-492
[3]   Decreased lesion formation in CCR2-/- mice reveals a role for chemokines in the initiation of atherosclerosis [J].
Boring, L ;
Gosling, J ;
Cleary, M ;
Charo, IF .
NATURE, 1998, 394 (6696) :894-897
[4]   Ccr5 but not Ccr1 deficiency reduces development of diet-induced atherosclerosis in mice [J].
Braunersreuther, Vincent ;
Zernecke, Alma ;
Arnaud, Claire ;
Liehn, Elisa A. ;
Steffens, Sabine ;
Shagdarsuren, Erdenechimeg ;
Bidzhekov, Kiril ;
Burger, Fabienne ;
Pelli, Graziano ;
Luckow, Bruno ;
Mach, Francois ;
Weber, Christian .
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2007, 27 (02) :373-379
[5]   Activation of TLR2 and TLR4 by minimally modified low-density lipoprotein in human macrophages and monocytes triggers the inflammatory response [J].
Chavez-Sanchez, L. ;
Madrid-Miller, A. ;
Chavez-Rueda, K. ;
Legorreta-Haquet, M. V. ;
Tesoro-Cruz, E. ;
Blanco-Favela, F. .
HUMAN IMMUNOLOGY, 2010, 71 (08) :737-744
[6]   Trichostatin A exacerbates atherosclerosis in low density lipoprotein receptor-deficient mice [J].
Choi, JH ;
Nam, KH ;
Kim, J ;
Baek, MW ;
Park, JE ;
Park, HY ;
Kwon, HJ ;
Kwon, OS ;
Kim, DY ;
Oh, GT .
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2005, 25 (11) :2404-2409
[7]   Myocardial infarction accelerates atherosclerosis [J].
Dutta, Partha ;
Courties, Gabriel ;
Wei, Ying ;
Leuschner, Florian ;
Gorbatov, Rostic ;
Robbins, Clinton S. ;
Iwamoto, Yoshiko ;
Thompson, Brian ;
Carlson, Alicia L. ;
Heidt, Timo ;
Majmudar, Maulik D. ;
Lasitschka, Felix ;
Etzrodt, Martin ;
Waterman, Peter ;
Waring, Michael T. ;
Chicoine, Adam T. ;
van der Laan, Anja M. ;
Niessen, Hans W. M. ;
Piek, Jan J. ;
Rubin, Barry B. ;
Butany, Jagdish ;
Stone, James R. ;
Katus, Hugo A. ;
Murphy, Sabina A. ;
Morrow, David A. ;
Sabatine, Marc S. ;
Vinegoni, Claudio ;
Moskowitz, Michael A. ;
Pittet, Mikael J. ;
Libby, Peter ;
Lin, Charles P. ;
Swirski, Filip K. ;
Weissleder, Ralph ;
Nahrendorf, Matthias .
NATURE, 2012, 487 (7407) :325-329
[8]   Absence of monocyte chemoattractant protein-1 reduces atherosclerosis in low density lipoprotein receptor-deficient mice [J].
Gu, L ;
Okada, Y ;
Clinton, SK ;
Gerard, C ;
Sukhova, GK ;
Libby, P ;
Rollins, BJ .
MOLECULAR CELL, 1998, 2 (02) :275-281
[9]   Inflammation and atherosclerosis [J].
Hansson, Goran K. ;
Robertson, Anna-Karin L. ;
Soderberg-Naucler, Cecilia .
ANNUAL REVIEW OF PATHOLOGY-MECHANISMS OF DISEASE, 2006, 1 (01) :297-329
[10]   The immune system in atherosclerosis [J].
Hansson, Goran K. ;
Hermansson, Andreas .
NATURE IMMUNOLOGY, 2011, 12 (03) :204-212